Citigroup’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.68M | Sell |
132,178
-109,702
| -45% | -$5.96M | ﹤0.01% | 1635 |
|
|
2025
Q4 | $11.2M | Sell |
241,880
-71,198
| -23% | -$3.18M | 0.01% | 1451 |
|
|
2025
Q3 | $11.3M | Sell |
313,078
-116,206
| -27% | -$3.85M | 0.01% | 1398 |
|
|
2025
Q2 | $14M | Sell |
429,284
-191,795
| -31% | -$6.29M | 0.01% | 1175 |
|
|
2025
Q1 | $23.5M | Buy |
621,079
+241,871
| +64% | +$19.3M | 0.02% | 882 |
|
|
2024
Q4 | $31M | Buy |
379,208
+158,665
| +72% | +$15.8M | 0.03% | 730 |
|
|
2024
Q3 | $25.2M | Buy |
220,543
+54,748
| +33% | +$4.93M | 0.02% | 835 |
|
|
2024
Q2 | $12.5M | Buy |
165,795
+20,928
| +14% | +$1.42M | 0.01% | 1131 |
|
|
2024
Q1 | $9.9M | Buy |
144,867
+65,955
| +84% | +$4.57M | 0.01% | 1256 |
|
|
2023
Q4 | $4.96M | Sell |
78,912
-16,527
| -17% | -$858K | 0.01% | 1601 |
|
|
2023
Q3 | $4.87M | Buy |
95,439
+16,816
| +21% | +$830K | 0.01% | 1446 |
|
|
2023
Q2 | $3.93M | Sell |
78,623
-69,463
| -47% | -$3.29M | 0.01% | 1657 |
|
|
2023
Q1 | $5.55M | Buy |
148,086
+29,320
| +25% | +$1.24M | 0.01% | 1452 |
|
|
2022
Q4 | $5.69M | Sell |
118,766
-36,673
| -24% | -$1.44M | 0.01% | 1405 |
|
|
2022
Q3 | $3.73M | Buy |
155,439
+99,373
| +177% | +$2.52M | 0.01% | 1717 |
|
|
2022
Q2 | $1.22M | Buy |
56,066
+43,686
| +353% | +$1.01M | ﹤0.01% | 2482 |
|
|
2022
Q1 | $299K | Sell |
12,380
-34,053
| -73% | -$744K | ﹤0.01% | 3842 |
|
|
2021
Q4 | $1.1M | Buy |
46,433
+21,159
| +84% | +$492K | ﹤0.01% | 3141 |
|
|
2021
Q3 | $641K | Sell |
25,274
-59,741
| -70% | -$1.45M | ﹤0.01% | 3441 |
|
|
2021
Q2 | $1.91M | Sell |
85,015
-28,311
| -25% | -$580K | ﹤0.01% | 2697 |
|
|
2021
Q1 | $2.24M | Buy |
113,326
+108,056
| +2,050% | +$2.72M | ﹤0.01% | 2416 |
|
|
2020
Q4 | $140K | Buy |
5,270
+4,396
| +503% | +$163K | ﹤0.01% | 5258 |
|
|
2020
Q3 | $43K | Buy |
+874
| New | +$34.8K | ﹤0.01% | 5694 |
|
Other funds holding PCVX
RCM
VPM
VCM
PBA
